Androgens and Female Sexuality: Molecular Insights, Neuroendocrine Crosstalk and Future Therapeutic Directions
Clinical and Experimental Obstetrics & Gynecology · 12.07.2023 · 50 (7)
DOI: 10.31083/j.ceog5007141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Obstetrics & Gynecology, online erschienen am 12.07.2023. Verfasst von Giulia Montan und 11 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The scientific community has recently directed its attention towards investigating the role of androgens in female sexuality. This narrative review aims to elucidate the central and peripheral androgen-mediated mechanisms involved in female sexual health and function. Additionally, the current state of androgen therapeutic options is discussed. Mechanism: We searched several scientific literature databases, including EMBASE, MEDLINE, PubMed Central, and Scopus, utilizing keywords, index terms, and MeSH terms, such as “androgen*”, “female sexuality”, “female sexual function”, “women’s sexual dysfunctions”, “androgen therapy in women”, and various combinations thereof. Findings in Brief: Progesterone or estrogens are commonly prescribed as first-line treatments for female sexual dysfunctions. However, these medications may frequently lead to therapeutic failure and cause harm by increasing sex-hormone-binding-globulin plasma levels and decreasing testosterone plasma concentrations. Currently, there are limited androgen therapies available for women, and the evidence for their effectiveness and safety is still limited.
Conclusions
The knowledge of neuroendocrine interactions that underlie sexual arousal and pleasure is rapidly expanding, and ongoing research is striving to develop more appropriate clinical practices for managing sexual dysfunctions in women.
Zitieren
APA
Montan, G., Carollo, M., Torres, L., Buzzaccarini, G., Giannini, A., Etrusco, A., Cosmi, E., Rigano, M., Chiantera, V., Laganà, A. S., Cucinella, G., & Gullo, G. (2023). Androgens and Female Sexuality: Molecular Insights, Neuroendocrine Crosstalk and Future Therapeutic Directions. Clinical and Experimental Obstetrics & Gynecology, 50(7). https://doi.org/10.31083/j.ceog5007141
Vancouver
Montan G, Carollo M, Torres L, Buzzaccarini G, Giannini A, Etrusco A, et al. Androgens and Female Sexuality: Molecular Insights, Neuroendocrine Crosstalk and Future Therapeutic Directions. Clinical and Experimental Obstetrics & Gynecology. 2023;50(7). doi:10.31083/j.ceog5007141
BibTeX
@article{Montan2023,
author = {Montan, Giulia and Carollo, Massimo and Torres, Luciano and Buzzaccarini, Giovanni and Giannini, Andrea and Etrusco, Andrea and Cosmi, Erich and Rigano, Marcello and Chiantera, Vito and Laganà, Antonio Simone and Cucinella, Gaspare and Gullo, Giuseppe},
title = {Androgens and Female Sexuality: Molecular Insights, Neuroendocrine Crosstalk and Future Therapeutic Directions},
journal = {Clinical and Experimental Obstetrics & Gynecology},
year = {2023},
volume = {50},
number = {7},
doi = {10.31083/j.ceog5007141}
}
EUVIMED